Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19

Actas Dermosifiliogr. 2021 Aug 2. doi: 10.1016/j.ad.2021.07.005. Online ahead of print.ABSTRACTHydroxychloroquine is an antimalarial drug with immunomodulatory, anti-inflammatory, antibacterial, and antiviral properties. It has a good safety profile, can be used in children and in pregnant and breastfeeding women, and does not suppress the immune system. Regular screening for retinopathy, one of the drug's most feared adverse effects, is necessary. Hydroxychloroquine is a widely used, essential drug in dermatology. Clinical response rates are good in lupus erythematous, where it is a first-line therapy, as well in numerous autoimmune/inflammatory diseases, including lichen planus, polymorphic light eruption, porphyria cutanea tarda, granuloma annulare, and sarcoidosis. In 2020, it was widely prescribed both to prevent and to treat COVID-19 caused by SARS-CoV-2. Its increased use led to serious supply shortages and in some cases stocks were entirely depleted. Recent meta-analyses have concluded that hydroxychloroquine is ineffective against COVID-19 and have advised against its use.PMID:34366433 | PMC:PMC8326180 | DOI:10.1016/j.ad.2021.07.005
Source: Actas Dermo-Sifiliograficas - Category: Dermatology Authors: Source Type: research